Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mammalian cell cycles without cyclin E-CDK2.

Qunyan Yu1, Piotr Sicinski

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

Cell Cycle (Georgetown, Tex.)
|January 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistance.

Genome medicine·2026
Same author

HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies.

Cancer discovery·2026
Same author

Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Transcriptional cyclin-dependent kinases Cdk8 and Cdk19 are required for normal macrophage differentiation.

Cell cycle (Georgetown, Tex.)·2025
Same author

Targeting Transcriptional Cyclin-Dependent Kinases in Cancer.

Molecular cancer therapeutics·2025
Same author

Cyclin C promotes development and progression of B-cell acute lymphoblastic leukemia by counteracting p53-mediated stress responses.

Haematologica·2024
Same journal

Circular RNA circ_0001829 attenuates G2/M arrest to promote hepatocyte proliferation by sponging miR-3095-3p following liver injury.

Cell cycle (Georgetown, Tex.)·2026
Same journal

Identification of PGF+ endothelial cells associated with plaque instability in carotid atherosclerosis by scRNA-seq and RNA-seq analysis.

Cell cycle (Georgetown, Tex.)·2026
Same journal

BMSCs-derived exosomal miR-196a-5p promotes macrophage M2 polarization and osteogenesis in postmenopausal osteoporosis through regulating Rspo2/Wnt/β-catenin signaling.

Cell cycle (Georgetown, Tex.)·2026
Same journal

MicroRNA-6833-3p drives prostate cancer progression and stemness by targeting the NUMB-mediated NOTCH signaling pathway.

Cell cycle (Georgetown, Tex.)·2026
Same journal

OTUD5 promotes AML progression by stabilizing SLC7A11 to suppress ferroptosis.

Cell cycle (Georgetown, Tex.)·2026
Same journal

MITF-Driven melanoma plasticity as a core mechanism of therapy resistance: integrating microenvironmental signaling, mechanotransduction, and metabolic reprogramming.

Cell cycle (Georgetown, Tex.)·2026
See all related articles

Mammalian E-type cyclins (cyclin E1 and E2) activate CDK2, a complex thought crucial for cell cycle progression. Recent findings, however, question this established role in both normal and cancer cells.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Mammalian E-type cyclins, specifically cyclin E1 and E2, are known regulators of cell proliferation.
  • These cyclins form complexes with cyclin-dependent kinase 2 (CDK2).

Purpose of the Study:

  • To investigate the critical function of cyclin E-CDK2 complexes in cell cycle progression.
  • To evaluate recent findings that challenge the established role of these complexes.

Main Methods:

  • Literature review of recent reports on cyclin E-CDK2 function.
  • Analysis of experimental data supporting or refuting the critical role of cyclin E-CDK2.

Main Results:

  • Cyclin E-CDK2 complexes have been widely considered essential for driving cell cycle progression.

Related Experiment Videos

  • Emerging evidence suggests a re-evaluation of their critical function is necessary.

    • Conclusions:

    • The precise role of cyclin E-CDK2 complexes in cell cycle control requires further investigation.
    • Recent studies indicate a potential shift in understanding their importance in normal and cancerous cells.